Literature DB >> 27267511

Anorexia nervosa in adults: The urgent need for novel outpatient treatments that work.

Daniel Le Grange1.   

Abstract

Anorexia nervosa (AN) is a serious psychiatric disorder that often follows a protracted course, and continues to confound those who attempt treatment once the patient has reached adulthood. Several randomized clinical trials for adults with AN have tested well-known therapies such as cognitive behavior therapy, supportive psychotherapies, or focal psychodynamic therapy, all of which have delivered frustratingly few helpful treatment strategies. Perhaps a different path could be pursued where we do not aim to cure all patients with 1 or 2 of these well-trodden therapies. Instead, a more targeted alternative, testing several novel approaches, could collectively reach a larger cohort of patients suffering from AN, the most lethal of all psychiatric disorders. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27267511      PMCID: PMC4902162          DOI: 10.1037/pst0000057

Source DB:  PubMed          Journal:  Psychotherapy (Chic)        ISSN: 0033-3204


  19 in total

1.  Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa.

Authors:  James Lock; Daniel Le Grange; W Stewart Agras; Ann Moye; Susan W Bryson; Booil Jo
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Eating disorders and antecedent anxiety disorders: a controlled study.

Authors:  C M Bulik; P F Sullivan; J L Fear; P R Joyce
Journal:  Acta Psychiatr Scand       Date:  1997-08       Impact factor: 6.392

Review 3.  Minimizing and treating chronicity in the eating disorders: a clinical overview.

Authors:  Stephen Wonderlich; James E Mitchell; Ross D Crosby; Tricia Cook Myers; Kelly Kadlec; Kim Lahaise; Lorraine Swan-Kremeier; Julie Dokken; Marnie Lange; Janna Dinkel; Michelle Jorgensen; Linda Schander
Journal:  Int J Eat Disord       Date:  2012-01-23       Impact factor: 4.861

4.  Three psychotherapies for anorexia nervosa: a randomized, controlled trial.

Authors:  Virginia V W McIntosh; Jennifer Jordan; Frances A Carter; Suzanne E Luty; Janice M McKenzie; Cynthia M Bulik; Christopher M A Frampton; Peter R Joyce
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

5.  Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.

Authors:  B Timothy Walsh; Allan S Kaplan; Evelyn Attia; Marion Olmsted; Michael Parides; Jacqueline C Carter; Kathleen M Pike; Michael J Devlin; Blake Woodside; Christina A Roberto; Wendi Rockert
Journal:  JAMA       Date:  2006-06-14       Impact factor: 56.272

6.  Is outpatient cognitive remediation therapy feasible to use in randomized clinical trials for anorexia nervosa?

Authors:  James Lock; W Stewart Agras; Kathleen Kara Fitzpatrick; Susan W Bryson; Booil Jo; Kate Tchanturia
Journal:  Int J Eat Disord       Date:  2013-04-29       Impact factor: 4.861

7.  Confronting fear using exposure and response prevention for anorexia nervosa: A randomized controlled pilot study.

Authors:  Joanna E Steinglass; Anne Marie Albano; H Blair Simpson; Yuanjia Wang; Jingjing Zou; Evelyn Attia; B Timothy Walsh
Journal:  Int J Eat Disord       Date:  2013-11-08       Impact factor: 4.861

8.  Relapse from remission at two- to four-year follow-up in two treatments for adolescent anorexia nervosa.

Authors:  Daniel Le Grange; James Lock; Erin C Accurso; W Stewart Agras; Alison Darcy; Sarah Forsberg; Susan W Bryson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-08-23       Impact factor: 8.829

9.  A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa.

Authors:  Daniel le Grange; Ross D Crosby; Paul J Rathouz; Bennett L Leventhal
Journal:  Arch Gen Psychiatry       Date:  2007-09

10.  Treating severe and enduring anorexia nervosa: a randomized controlled trial.

Authors:  S Touyz; D Le Grange; H Lacey; P Hay; R Smith; S Maguire; B Bamford; K M Pike; R D Crosby
Journal:  Psychol Med       Date:  2013-05-03       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.